Navigation Links
Intarcia Enrolls First Patients in "FREEDOM" Global Phase 3 Program for ITCA 650 in Type 2 Diabetes
Date:3/21/2013

eries is very exciting and gratifying milestone for us."

Concurrent with FREEDOM-1, Intarcia will also be conducting an open-label study, called FREEDOM-1 HBL (high baseline), in patients who meet all eligibility criteria for FREEDOM-1, but whose baseline HbA1c is greater than 10%. All patients in this study will be treated with ITCA 650 20 mcg/d for the first 3 months and with ITCA 650 60 mcg/d for the next 6 months.

About the FREEDOM Program

The FREEDOM program is designed to evaluate the safety and efficacy of ITCA 650 (continuous subcutaneous delivery of exenatide) for the treatment of type 2 diabetes. Intarcia expects to enroll greater than 4,000 patients at more than 500 clinical trial sites in more than 30 countries. The clinical studies will cover a broad range of patients whose diabetes is not controlled by oral anti-diabetes medications including metformin and metformin-based combinations. FREEDOM-1 is a U.S.-only, placebo-controlled, double-blind study comparing ITCA 650 doses of 40 mcg/d and 60 mcg/d to placebo; the FREEDOM-2 study will be a 500-patient, global, active-comparator controlled, double-blind, double-dummy study in patients on metformin only, comparing ITCA 650 20 mcg/d for 13 weeks plus ITCA 650 60 mcg/d for 39 weeks to patients taking sitagliptin (Januvia®, Merck); FREEDOM-CVO is a global, placebo-controlled cardiovascular outcomes study that will examine the safety of ITCA 650 at 60 mcg/d vs. placebo in approximately 3,000 patients on a variety of approved anti-diabetes therapies.

About ITCA 650

ITCA 650 (continuous subcutaneous delivery of exenatide) is being developed for the treatment of type 2 diabetes. The investigational therapy employs Intarcia's proprietary technology platform involving a matchstick-size, miniature osmotic pump that is inserted subcutaneously to provide continuous and consistent drug therapy, and the company's proprietary formulation technology, which maintains stability of
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Intarcia Appoints Owen Hughes Chief Business Officer and Head of Corporate Development
2. ROX Medical enrolls first UK patients in CONTROL-HTN hypertension trial at Eastbourne General Hospital
3. ROX Medical enrolls first patients in Ireland for CONTROL-HTN hypertension trial at Beaumont and Mater Private Hospitals
4. Adynxx Enrolls First Patient in Phase 2 Proof-of-Concept Study for AYX1, Lead Compound for the Prevention of Post-Surgical Pain
5. Boehringer Ingelheim Enrolls First Patients in Pivotal Phase 3 Interferon-Free Hepatitis C Trial Program
6. CalHIPSO Enrolls Over 7,700 Providers in EHR Implementation Program, Hits Other Key Milestones After First Two Years
7. PQA and CECity Launch Joint Venture to Deliver First National Pharmacy Quality Measurement, Benchmarking and Reporting Platform for Pharmacies and Health Plans
8. First Patients Dosed in Proof-of-Concept Clinical Study of Alder Biopharmaceuticals Lead Therapeutic Candidate for Treatment of Migraine, ALD403
9. Johnson & Johnson to Host Analyst Conference Call on First-Quarter Results
10. Wyckoff Heights Medical Center Is First New York Hospital to Offer Asthmapolis Mobile Asthma Management Program
11. Quest Diagnostics Launches Dementia Diagnostic Panel, First in Industry for Treatable Forms of Cognitive Impairment Based on Medical Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... -- Mirati Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX ),  a targeted ... will be presenting at the 2015 Wedbush PacGrow Healthcare Conference ... a.m. PT) in New York . ... Mirati, will provide a corporate overview. A live ... "Investors" page of Mirati,s corporate website at www.mirati.com . ...
(Date:8/4/2015)... IRVINE, Calif., Aug. 4, 2015  Syneron Medical Ltd. (NASDAQ: ... announced financial results for the three month period ended June ... Recent Non-GAAP 1 Highlights: , ... constant currency. , North American product sales grew 45% ... in constant currency, including 14% product growth in the EMEA ...
(Date:8/3/2015)... 2015  BC Technical, the nation,s leading non-OEM provider ... Systems, one of the largest MRI service providers specializing ... Valley Medical Systems allows BC Technical to expand its ... "We couldn,t be more excited about this ... of BC Technical. "The Ohio Valley engineers are true ...
Breaking Medicine Technology:Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 2Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 2Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 3Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 4Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 5Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 6Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 7Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 8Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 9Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 10Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 11Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 12Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 13Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 14Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 15Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 16Syneron Medical Reports Revenue of $73.5 Million for the Second Quarter 2015 17BC Technical Acquires Ohio Valley Medical Systems 2
... WASHINGTON, Dec. 15 Today,s New York Times ... Spurs Division," illustrates an internal renal community reimbursement debate that ... their life-saving immunosuppressive medications beyond the current 36-month Medicare program ... transplant patient coverage to preserve the lives of transplant kidney ...
... , , NEW YORK, Dec. 15 ... available in its catalogue: , Systemic Lupus Erythematosus ... , http://www.reportlinker.com/p0167308/Systemic-Lupus-Erythematosus---Drug-Pipeline-Analysis-and-Market-Forecasts-to-2015.html , Systemic Lupus ... 2015 , Summary , GlobalData, the industry ...
Cached Medicine Technology:AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 2Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 3Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 4Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 5Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 6Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 7Reportlinker Adds Systemic Lupus Erythematosus - Drug Pipeline Analysis and Market Forecasts to 2015 8
(Date:8/4/2015)... PA (PRWEB) , ... August 04, 2015 , ... ... medical information, checking with “Dr. Google” before calling a physician. In an effort ... is the first health care provider in Pennsylvania to publicly share patient satisfaction ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... announced that Bruce McCalley joins its executive leadership team as Senior Vice President ... success at technology companies and expanding global markets with a special emphasis on ...
(Date:8/4/2015)... Morristown & Montclair, NJ (PRWEB) , ... August 04, 2015 , ... ... certificate program in Arts and Health, the first of its kind in New Jersey, ... The University’s College of the Arts and Graduate School partnered with Atlantic Health System, ...
(Date:8/4/2015)... , ... August 04, 2015 , ... It’s been called ... describe the customer experience inside Naimie’s Beauty Center in LA. Now MENAJI is part ... to look better. , Naimie’s Beauty Center has been a favorite of makeup artists ...
(Date:8/4/2015)... ... August 04, 2015 , ... ... (PHR) product has achieved Office of the National Coordinator for Health Information ... Group. HealthCenter delivers the highest quality personal health record and patient portal ...
Breaking Medicine News(10 mins):Health News:UPMC 1st in Pa. to Share Provider Ratings 2Health News:UPMC 1st in Pa. to Share Provider Ratings 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 2Health News:Atlantic Health System & Montclair State University Launch Graduate Program in Arts & Health 3Health News:MENAJI Shines in Make-Up Mecca for Stars 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 2Health News:MedicaSoft's HealthCenter Earns ONC-HIT Certification from Drummond Group 3
... stress and depression ever recorded, following extremely high of ... published in BMC Psychiatry says today. , The study, ... Medicine and Gulu University has found that 54% of ... 67% showed signs of depression. , Bayard Roberts, lead ...
... designed for ... your carry-on, SAN RAFAEL, Calif., ... to soften nerves during,flight delays and long waits in airport lines, rich ... pre-packed in a zip-lock,tote to pass airport security and cut back on ...
... into Common Everyday Language: ,A Novel Diet, by ... ... seen a more solid, practical and realistic approach to,weight control." -- Nutritionist, ... of "A Novel Diet,",published by iUniverse, Inc., which offers a unique approach ...
... BALTIMORE, June 3 A new website,( http://www.shofarcoalition.org ... and emotional abuse and neglect of Jewish children. ... specialized services,for children, adolescents, and adults who are ... Shofar Coalition is a Baltimore-based,group, the information on ...
... conjugate vaccine has been a boon in reducing the ... medical community must not get complacent, as non-vaccine strains, ... scientists at a meeting today in Boston. , We ... burden of pneumococcal disease. It targets 7 strains ...
... Use of Risky Gadolinium Injections, CHICAGO, ... Renal,a gadolinium-free procedure, offers a safe alternative ... and Magnetic,Resonance Imaging (MRI) scans for patients ... has traditionally required the injection of,a gadolinium ...
Cached Medicine News:Health News:Aromatherapy Luxuries for the Eco-Friendly Traveler 2Health News:Who Knew You Could Learn to Lose Weight by Reading an Enjoyable Novel? 2Health News:New Program/Website Targets Jewish Children, Teens, and Adults Suffering from the Impact of Childhood Maltreatment 2Health News:Despite vaccine, public should not get complacent about pneumococcal disease 2Health News:NOVA(R) Renal: A Safe Alternative to Contrast Enhanced MRA/MRI 2
Integrated electronics, three-chip CCD camera with PAL and NTSC output at 750 lines, RGB-video. 44mm x 49mm x 75mm, 180 grams....
Large image and wide-angle design....
High intensity halogen lamp with built-in, switchable spare. Optical light concentrator to optimize existing light energy....
PDA application listing specific ICD-9 coding listed in new Medicare National Coverage Determinations....
Medicine Products: